Inhibition of methionine uptake by methotrexate in mouse leukemia L1210 cells. 1987

K J Scanlon, and A R Cashmore, and M Kashani-Sabet, and M Pallai, and R N Dreyer, and B A Moroson, and M Saketos

Methionine-auxotrophic L1210 cells were used to study the effect of methotrexate (MTX) on methionine uptake and metabolism. MTX was shown to inhibit amino acid transport systems and cause a decrease of methionine uptake into L1210 cells. Conversely, a nonmetabolizable amino acid analogue reduced MTX uptake into L1210 cells. MTX also blocked the transfer of the beta carbon from serine into methionine. Therefore, methionine deprivation may be an additional mechanism of action for MTX in methionine-auxotrophic tumor cells.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008715 Methionine A sulfur-containing essential L-amino acid that is important in many body functions. L-Methionine,Liquimeth,Methionine, L-Isomer,Pedameth,L-Isomer Methionine,Methionine, L Isomer
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001693 Biological Transport, Active The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy. Active Transport,Uphill Transport,Active Biological Transport,Biologic Transport, Active,Transport, Active Biological,Active Biologic Transport,Transport, Active,Transport, Active Biologic,Transport, Uphill
D012694 Serine A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids. L-Serine,L Serine
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

K J Scanlon, and A R Cashmore, and M Kashani-Sabet, and M Pallai, and R N Dreyer, and B A Moroson, and M Saketos
March 1984, Cancer treatment reports,
K J Scanlon, and A R Cashmore, and M Kashani-Sabet, and M Pallai, and R N Dreyer, and B A Moroson, and M Saketos
January 1975, Biochimica et biophysica acta,
K J Scanlon, and A R Cashmore, and M Kashani-Sabet, and M Pallai, and R N Dreyer, and B A Moroson, and M Saketos
January 1983, Progress in clinical and biological research,
K J Scanlon, and A R Cashmore, and M Kashani-Sabet, and M Pallai, and R N Dreyer, and B A Moroson, and M Saketos
December 1967, Cancer research,
K J Scanlon, and A R Cashmore, and M Kashani-Sabet, and M Pallai, and R N Dreyer, and B A Moroson, and M Saketos
August 1987, Cancer letters,
K J Scanlon, and A R Cashmore, and M Kashani-Sabet, and M Pallai, and R N Dreyer, and B A Moroson, and M Saketos
January 1998, Oncology reports,
K J Scanlon, and A R Cashmore, and M Kashani-Sabet, and M Pallai, and R N Dreyer, and B A Moroson, and M Saketos
March 1985, Journal of the National Cancer Institute,
K J Scanlon, and A R Cashmore, and M Kashani-Sabet, and M Pallai, and R N Dreyer, and B A Moroson, and M Saketos
March 1981, Cancer research,
K J Scanlon, and A R Cashmore, and M Kashani-Sabet, and M Pallai, and R N Dreyer, and B A Moroson, and M Saketos
December 1973, Cancer research,
K J Scanlon, and A R Cashmore, and M Kashani-Sabet, and M Pallai, and R N Dreyer, and B A Moroson, and M Saketos
April 1980, Cancer research,
Copied contents to your clipboard!